Global Modified NSAIDs Supply, Demand and Key Producers, 2026-2032
The global Modified NSAIDs market size is expected to reach $ 12432 million by 2032, rising at a market growth of 7.8% CAGR during the forecast period (2026-2032).
Modified nonsteroidal anti-inflammatory drugs (NSAIDs) are drugs developed from traditional NSAIDs (such as ibuprofen, indomethacin, and diclofenac) through molecular structure modification, improved formulation processes, or combination therapy strategies to reduce side effects and improve safety and efficacy. The main side effects of traditional NSAIDs are gastrointestinal damage, cardiovascular risk, and kidney impairment. Modified NSAIDs significantly reduce these risks and improve long-term safety through structural or formulation innovations. The product is priced at approximately $5,000 per kg, with global sales of approximately 1.46 million kg.
The upstream sector consists of active pharmaceutical ingredients (COX inhibitors, synthetic intermediates); the midstream sector comprises modified formulation companies (controlled-release tablets, transdermal patches, and combination formulations); and the downstream sector includes hospitals, pharmacies, and the OTC market. Future trends are safety-driven: selective COX-2 inhibitors and novel formulations will gradually replace traditional NSAIDs, especially in the elderly and patients with chronic diseases. Precision medicine and biologics will also become complementary treatment options.
This report studies the global Modified NSAIDs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Modified NSAIDs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Modified NSAIDs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Modified NSAIDs total production and demand, 2021-2032, (Tons)
Global Modified NSAIDs total production value, 2021-2032, (USD Million)
Global Modified NSAIDs production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global Modified NSAIDs consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: Modified NSAIDs domestic production, consumption, key domestic manufacturers and share
Global Modified NSAIDs production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global Modified NSAIDs production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global Modified NSAIDs production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global Modified NSAIDs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Novartis, Bayer, AbbVie, Takeda, Sanofi, GSK, Johnson & Johnson, Teva, Sun Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Modified NSAIDs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Modified NSAIDs Market, By Region:
1. How big is the global Modified NSAIDs market?
2. What is the demand of the global Modified NSAIDs market?
3. What is the year over year growth of the global Modified NSAIDs market?
4. What is the production and production value of the global Modified NSAIDs market?
5. Who are the key producers in the global Modified NSAIDs market?
6. What are the growth factors driving the market demand?
Modified nonsteroidal anti-inflammatory drugs (NSAIDs) are drugs developed from traditional NSAIDs (such as ibuprofen, indomethacin, and diclofenac) through molecular structure modification, improved formulation processes, or combination therapy strategies to reduce side effects and improve safety and efficacy. The main side effects of traditional NSAIDs are gastrointestinal damage, cardiovascular risk, and kidney impairment. Modified NSAIDs significantly reduce these risks and improve long-term safety through structural or formulation innovations. The product is priced at approximately $5,000 per kg, with global sales of approximately 1.46 million kg.
The upstream sector consists of active pharmaceutical ingredients (COX inhibitors, synthetic intermediates); the midstream sector comprises modified formulation companies (controlled-release tablets, transdermal patches, and combination formulations); and the downstream sector includes hospitals, pharmacies, and the OTC market. Future trends are safety-driven: selective COX-2 inhibitors and novel formulations will gradually replace traditional NSAIDs, especially in the elderly and patients with chronic diseases. Precision medicine and biologics will also become complementary treatment options.
This report studies the global Modified NSAIDs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Modified NSAIDs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Modified NSAIDs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Modified NSAIDs total production and demand, 2021-2032, (Tons)
Global Modified NSAIDs total production value, 2021-2032, (USD Million)
Global Modified NSAIDs production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global Modified NSAIDs consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: Modified NSAIDs domestic production, consumption, key domestic manufacturers and share
Global Modified NSAIDs production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global Modified NSAIDs production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global Modified NSAIDs production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global Modified NSAIDs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Novartis, Bayer, AbbVie, Takeda, Sanofi, GSK, Johnson & Johnson, Teva, Sun Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Modified NSAIDs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Modified NSAIDs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- COX-2 Selective Inhibitors
- NO-NSAIDs (Nitric Oxide Releasers)
- Others
- Acute Pain Management
- Chronic Inflammation (Rheumatoid Arthritis, Osteoarthritis)
- Others
- Sustained-Release/Controlled-Release Tablets
- Transdermal Patches, Gels
- Microencapsulated Formulations
- Hospital Clinical Department
- Sports Medicine
- Others
- Pfizer
- Novartis
- Bayer
- AbbVie
- Takeda
- Sanofi
- GSK
- Johnson & Johnson
- Teva
- Sun Pharma
- Cipla
- Dr. Reddy's
- Aurobindo
- Zydus Cadila
- Torrent Pharma
- Viatris
- Apotex
- Hikma
- Jiangsu Hengrui Pharmaceuticals
- Suzhou Homesun Pharmaceutical
- CSPC Pharmaceutical
- Zhejiang Sundoc Pharmaceutical
1. How big is the global Modified NSAIDs market?
2. What is the demand of the global Modified NSAIDs market?
3. What is the year over year growth of the global Modified NSAIDs market?
4. What is the production and production value of the global Modified NSAIDs market?
5. Who are the key producers in the global Modified NSAIDs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Modified NSAIDs Introduction
1.2 World Modified NSAIDs Supply & Forecast
1.2.1 World Modified NSAIDs Production Value (2021 & 2025 & 2032)
1.2.2 World Modified NSAIDs Production (2021-2032)
1.2.3 World Modified NSAIDs Pricing Trends (2021-2032)
1.3 World Modified NSAIDs Production by Region (Based on Production Site)
1.3.1 World Modified NSAIDs Production Value by Region (2021-2032)
1.3.2 World Modified NSAIDs Production by Region (2021-2032)
1.3.3 World Modified NSAIDs Average Price by Region (2021-2032)
1.3.4 North America Modified NSAIDs Production (2021-2032)
1.3.5 Europe Modified NSAIDs Production (2021-2032)
1.3.6 China Modified NSAIDs Production (2021-2032)
1.3.7 Japan Modified NSAIDs Production (2021-2032)
1.3.8 India Modified NSAIDs Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Modified NSAIDs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Modified NSAIDs Major Market Trends
2 DEMAND SUMMARY
2.1 World Modified NSAIDs Demand (2021-2032)
2.2 World Modified NSAIDs Consumption by Region
2.2.1 World Modified NSAIDs Consumption by Region (2021-2026)
2.2.2 World Modified NSAIDs Consumption Forecast by Region (2027-2032)
2.3 United States Modified NSAIDs Consumption (2021-2032)
2.4 China Modified NSAIDs Consumption (2021-2032)
2.5 Europe Modified NSAIDs Consumption (2021-2032)
2.6 Japan Modified NSAIDs Consumption (2021-2032)
2.7 South Korea Modified NSAIDs Consumption (2021-2032)
2.8 ASEAN Modified NSAIDs Consumption (2021-2032)
2.9 India Modified NSAIDs Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Modified NSAIDs Production Value by Manufacturer (2021-2026)
3.2 World Modified NSAIDs Production by Manufacturer (2021-2026)
3.3 World Modified NSAIDs Average Price by Manufacturer (2021-2026)
3.4 Modified NSAIDs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Modified NSAIDs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Modified NSAIDs in 2025
3.5.3 Global Concentration Ratios (CR8) for Modified NSAIDs in 2025
3.6 Modified NSAIDs Market: Overall Company Footprint Analysis
3.6.1 Modified NSAIDs Market: Region Footprint
3.6.2 Modified NSAIDs Market: Company Product Type Footprint
3.6.3 Modified NSAIDs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Modified NSAIDs Production Value Comparison
4.1.1 United States VS China: Modified NSAIDs Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Modified NSAIDs Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Modified NSAIDs Production Comparison
4.2.1 United States VS China: Modified NSAIDs Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Modified NSAIDs Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Modified NSAIDs Consumption Comparison
4.3.1 United States VS China: Modified NSAIDs Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Modified NSAIDs Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Modified NSAIDs Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Modified NSAIDs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Modified NSAIDs Production Value (2021-2026)
4.4.3 United States Based Manufacturers Modified NSAIDs Production (2021-2026)
4.5 China Based Modified NSAIDs Manufacturers and Market Share
4.5.1 China Based Modified NSAIDs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Modified NSAIDs Production Value (2021-2026)
4.5.3 China Based Manufacturers Modified NSAIDs Production (2021-2026)
4.6 Rest of World Based Modified NSAIDs Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Modified NSAIDs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Modified NSAIDs Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Modified NSAIDs Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Modified NSAIDs Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 COX-2 Selective Inhibitors
5.2.2 NO-NSAIDs (Nitric Oxide Releasers)
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Modified NSAIDs Production by Type (2021-2032)
5.3.2 World Modified NSAIDs Production Value by Type (2021-2032)
5.3.3 World Modified NSAIDs Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY APPLICATION SCENARIOS
6.1 World Modified NSAIDs Market Size Overview by Application Scenarios: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application Scenarios
6.2.1 Acute Pain Management
6.2.2 Chronic Inflammation (Rheumatoid Arthritis, Osteoarthritis)
6.2.3 Others
6.3 Market Segment by Application Scenarios
6.3.1 World Modified NSAIDs Production by Application Scenarios (2021-2032)
6.3.2 World Modified NSAIDs Production Value by Application Scenarios (2021-2032)
6.3.3 World Modified NSAIDs Average Price by Application Scenarios (2021-2032)
7 MARKET ANALYSIS BY MANUFACTURING PROCESS
7.1 World Modified NSAIDs Market Size Overview by Manufacturing Process: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Manufacturing Process
7.2.1 Sustained-Release/Controlled-Release Tablets
7.2.2 Transdermal Patches, Gels
7.2.3 Microencapsulated Formulations
7.3 Market Segment by Manufacturing Process
7.3.1 World Modified NSAIDs Production by Manufacturing Process (2021-2032)
7.3.2 World Modified NSAIDs Production Value by Manufacturing Process (2021-2032)
7.3.3 World Modified NSAIDs Average Price by Manufacturing Process (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Modified NSAIDs Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital Clinical Department
8.2.2 Sports Medicine
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Modified NSAIDs Production by Application (2021-2032)
8.3.2 World Modified NSAIDs Production Value by Application (2021-2032)
8.3.3 World Modified NSAIDs Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Pfizer
9.1.1 Pfizer Details
9.1.2 Pfizer Major Business
9.1.3 Pfizer Modified NSAIDs Product and Services
9.1.4 Pfizer Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Pfizer Recent Developments/Updates
9.1.6 Pfizer Competitive Strengths & Weaknesses
9.2 Novartis
9.2.1 Novartis Details
9.2.2 Novartis Major Business
9.2.3 Novartis Modified NSAIDs Product and Services
9.2.4 Novartis Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Novartis Recent Developments/Updates
9.2.6 Novartis Competitive Strengths & Weaknesses
9.3 Bayer
9.3.1 Bayer Details
9.3.2 Bayer Major Business
9.3.3 Bayer Modified NSAIDs Product and Services
9.3.4 Bayer Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Bayer Recent Developments/Updates
9.3.6 Bayer Competitive Strengths & Weaknesses
9.4 AbbVie
9.4.1 AbbVie Details
9.4.2 AbbVie Major Business
9.4.3 AbbVie Modified NSAIDs Product and Services
9.4.4 AbbVie Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 AbbVie Recent Developments/Updates
9.4.6 AbbVie Competitive Strengths & Weaknesses
9.5 Takeda
9.5.1 Takeda Details
9.5.2 Takeda Major Business
9.5.3 Takeda Modified NSAIDs Product and Services
9.5.4 Takeda Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Takeda Recent Developments/Updates
9.5.6 Takeda Competitive Strengths & Weaknesses
9.6 Sanofi
9.6.1 Sanofi Details
9.6.2 Sanofi Major Business
9.6.3 Sanofi Modified NSAIDs Product and Services
9.6.4 Sanofi Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Sanofi Recent Developments/Updates
9.6.6 Sanofi Competitive Strengths & Weaknesses
9.7 GSK
9.7.1 GSK Details
9.7.2 GSK Major Business
9.7.3 GSK Modified NSAIDs Product and Services
9.7.4 GSK Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 GSK Recent Developments/Updates
9.7.6 GSK Competitive Strengths & Weaknesses
9.8 Johnson & Johnson
9.8.1 Johnson & Johnson Details
9.8.2 Johnson & Johnson Major Business
9.8.3 Johnson & Johnson Modified NSAIDs Product and Services
9.8.4 Johnson & Johnson Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Johnson & Johnson Recent Developments/Updates
9.8.6 Johnson & Johnson Competitive Strengths & Weaknesses
9.9 Teva
9.9.1 Teva Details
9.9.2 Teva Major Business
9.9.3 Teva Modified NSAIDs Product and Services
9.9.4 Teva Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Teva Recent Developments/Updates
9.9.6 Teva Competitive Strengths & Weaknesses
9.10 Sun Pharma
9.10.1 Sun Pharma Details
9.10.2 Sun Pharma Major Business
9.10.3 Sun Pharma Modified NSAIDs Product and Services
9.10.4 Sun Pharma Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Sun Pharma Recent Developments/Updates
9.10.6 Sun Pharma Competitive Strengths & Weaknesses
9.11 Cipla
9.11.1 Cipla Details
9.11.2 Cipla Major Business
9.11.3 Cipla Modified NSAIDs Product and Services
9.11.4 Cipla Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Cipla Recent Developments/Updates
9.11.6 Cipla Competitive Strengths & Weaknesses
9.12 Dr. Reddy's
9.12.1 Dr. Reddy's Details
9.12.2 Dr. Reddy's Major Business
9.12.3 Dr. Reddy's Modified NSAIDs Product and Services
9.12.4 Dr. Reddy's Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Dr. Reddy's Recent Developments/Updates
9.12.6 Dr. Reddy's Competitive Strengths & Weaknesses
9.13 Aurobindo
9.13.1 Aurobindo Details
9.13.2 Aurobindo Major Business
9.13.3 Aurobindo Modified NSAIDs Product and Services
9.13.4 Aurobindo Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Aurobindo Recent Developments/Updates
9.13.6 Aurobindo Competitive Strengths & Weaknesses
9.14 Zydus Cadila
9.14.1 Zydus Cadila Details
9.14.2 Zydus Cadila Major Business
9.14.3 Zydus Cadila Modified NSAIDs Product and Services
9.14.4 Zydus Cadila Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Zydus Cadila Recent Developments/Updates
9.14.6 Zydus Cadila Competitive Strengths & Weaknesses
9.15 Torrent Pharma
9.15.1 Torrent Pharma Details
9.15.2 Torrent Pharma Major Business
9.15.3 Torrent Pharma Modified NSAIDs Product and Services
9.15.4 Torrent Pharma Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Torrent Pharma Recent Developments/Updates
9.15.6 Torrent Pharma Competitive Strengths & Weaknesses
9.16 Viatris
9.16.1 Viatris Details
9.16.2 Viatris Major Business
9.16.3 Viatris Modified NSAIDs Product and Services
9.16.4 Viatris Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Viatris Recent Developments/Updates
9.16.6 Viatris Competitive Strengths & Weaknesses
9.17 Apotex
9.17.1 Apotex Details
9.17.2 Apotex Major Business
9.17.3 Apotex Modified NSAIDs Product and Services
9.17.4 Apotex Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Apotex Recent Developments/Updates
9.17.6 Apotex Competitive Strengths & Weaknesses
9.18 Hikma
9.18.1 Hikma Details
9.18.2 Hikma Major Business
9.18.3 Hikma Modified NSAIDs Product and Services
9.18.4 Hikma Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Hikma Recent Developments/Updates
9.18.6 Hikma Competitive Strengths & Weaknesses
9.19 Jiangsu Hengrui Pharmaceuticals
9.19.1 Jiangsu Hengrui Pharmaceuticals Details
9.19.2 Jiangsu Hengrui Pharmaceuticals Major Business
9.19.3 Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Product and Services
9.19.4 Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
9.19.6 Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
9.20 Suzhou Homesun Pharmaceutical
9.20.1 Suzhou Homesun Pharmaceutical Details
9.20.2 Suzhou Homesun Pharmaceutical Major Business
9.20.3 Suzhou Homesun Pharmaceutical Modified NSAIDs Product and Services
9.20.4 Suzhou Homesun Pharmaceutical Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Suzhou Homesun Pharmaceutical Recent Developments/Updates
9.20.6 Suzhou Homesun Pharmaceutical Competitive Strengths & Weaknesses
9.21 CSPC Pharmaceutical
9.21.1 CSPC Pharmaceutical Details
9.21.2 CSPC Pharmaceutical Major Business
9.21.3 CSPC Pharmaceutical Modified NSAIDs Product and Services
9.21.4 CSPC Pharmaceutical Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 CSPC Pharmaceutical Recent Developments/Updates
9.21.6 CSPC Pharmaceutical Competitive Strengths & Weaknesses
9.22 Zhejiang Sundoc Pharmaceutical
9.22.1 Zhejiang Sundoc Pharmaceutical Details
9.22.2 Zhejiang Sundoc Pharmaceutical Major Business
9.22.3 Zhejiang Sundoc Pharmaceutical Modified NSAIDs Product and Services
9.22.4 Zhejiang Sundoc Pharmaceutical Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 Zhejiang Sundoc Pharmaceutical Recent Developments/Updates
9.22.6 Zhejiang Sundoc Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Modified NSAIDs Industry Chain
10.2 Modified NSAIDs Upstream Analysis
10.2.1 Modified NSAIDs Core Raw Materials
10.2.2 Main Manufacturers of Modified NSAIDs Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Modified NSAIDs Production Mode
10.6 Modified NSAIDs Procurement Model
10.7 Modified NSAIDs Industry Sales Model and Sales Channels
10.7.1 Modified NSAIDs Sales Model
10.7.2 Modified NSAIDs Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Modified NSAIDs Introduction
1.2 World Modified NSAIDs Supply & Forecast
1.2.1 World Modified NSAIDs Production Value (2021 & 2025 & 2032)
1.2.2 World Modified NSAIDs Production (2021-2032)
1.2.3 World Modified NSAIDs Pricing Trends (2021-2032)
1.3 World Modified NSAIDs Production by Region (Based on Production Site)
1.3.1 World Modified NSAIDs Production Value by Region (2021-2032)
1.3.2 World Modified NSAIDs Production by Region (2021-2032)
1.3.3 World Modified NSAIDs Average Price by Region (2021-2032)
1.3.4 North America Modified NSAIDs Production (2021-2032)
1.3.5 Europe Modified NSAIDs Production (2021-2032)
1.3.6 China Modified NSAIDs Production (2021-2032)
1.3.7 Japan Modified NSAIDs Production (2021-2032)
1.3.8 India Modified NSAIDs Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Modified NSAIDs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Modified NSAIDs Major Market Trends
2 DEMAND SUMMARY
2.1 World Modified NSAIDs Demand (2021-2032)
2.2 World Modified NSAIDs Consumption by Region
2.2.1 World Modified NSAIDs Consumption by Region (2021-2026)
2.2.2 World Modified NSAIDs Consumption Forecast by Region (2027-2032)
2.3 United States Modified NSAIDs Consumption (2021-2032)
2.4 China Modified NSAIDs Consumption (2021-2032)
2.5 Europe Modified NSAIDs Consumption (2021-2032)
2.6 Japan Modified NSAIDs Consumption (2021-2032)
2.7 South Korea Modified NSAIDs Consumption (2021-2032)
2.8 ASEAN Modified NSAIDs Consumption (2021-2032)
2.9 India Modified NSAIDs Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Modified NSAIDs Production Value by Manufacturer (2021-2026)
3.2 World Modified NSAIDs Production by Manufacturer (2021-2026)
3.3 World Modified NSAIDs Average Price by Manufacturer (2021-2026)
3.4 Modified NSAIDs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Modified NSAIDs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Modified NSAIDs in 2025
3.5.3 Global Concentration Ratios (CR8) for Modified NSAIDs in 2025
3.6 Modified NSAIDs Market: Overall Company Footprint Analysis
3.6.1 Modified NSAIDs Market: Region Footprint
3.6.2 Modified NSAIDs Market: Company Product Type Footprint
3.6.3 Modified NSAIDs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Modified NSAIDs Production Value Comparison
4.1.1 United States VS China: Modified NSAIDs Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Modified NSAIDs Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Modified NSAIDs Production Comparison
4.2.1 United States VS China: Modified NSAIDs Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Modified NSAIDs Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Modified NSAIDs Consumption Comparison
4.3.1 United States VS China: Modified NSAIDs Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Modified NSAIDs Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Modified NSAIDs Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Modified NSAIDs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Modified NSAIDs Production Value (2021-2026)
4.4.3 United States Based Manufacturers Modified NSAIDs Production (2021-2026)
4.5 China Based Modified NSAIDs Manufacturers and Market Share
4.5.1 China Based Modified NSAIDs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Modified NSAIDs Production Value (2021-2026)
4.5.3 China Based Manufacturers Modified NSAIDs Production (2021-2026)
4.6 Rest of World Based Modified NSAIDs Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Modified NSAIDs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Modified NSAIDs Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Modified NSAIDs Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Modified NSAIDs Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 COX-2 Selective Inhibitors
5.2.2 NO-NSAIDs (Nitric Oxide Releasers)
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Modified NSAIDs Production by Type (2021-2032)
5.3.2 World Modified NSAIDs Production Value by Type (2021-2032)
5.3.3 World Modified NSAIDs Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY APPLICATION SCENARIOS
6.1 World Modified NSAIDs Market Size Overview by Application Scenarios: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application Scenarios
6.2.1 Acute Pain Management
6.2.2 Chronic Inflammation (Rheumatoid Arthritis, Osteoarthritis)
6.2.3 Others
6.3 Market Segment by Application Scenarios
6.3.1 World Modified NSAIDs Production by Application Scenarios (2021-2032)
6.3.2 World Modified NSAIDs Production Value by Application Scenarios (2021-2032)
6.3.3 World Modified NSAIDs Average Price by Application Scenarios (2021-2032)
7 MARKET ANALYSIS BY MANUFACTURING PROCESS
7.1 World Modified NSAIDs Market Size Overview by Manufacturing Process: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Manufacturing Process
7.2.1 Sustained-Release/Controlled-Release Tablets
7.2.2 Transdermal Patches, Gels
7.2.3 Microencapsulated Formulations
7.3 Market Segment by Manufacturing Process
7.3.1 World Modified NSAIDs Production by Manufacturing Process (2021-2032)
7.3.2 World Modified NSAIDs Production Value by Manufacturing Process (2021-2032)
7.3.3 World Modified NSAIDs Average Price by Manufacturing Process (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Modified NSAIDs Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital Clinical Department
8.2.2 Sports Medicine
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Modified NSAIDs Production by Application (2021-2032)
8.3.2 World Modified NSAIDs Production Value by Application (2021-2032)
8.3.3 World Modified NSAIDs Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Pfizer
9.1.1 Pfizer Details
9.1.2 Pfizer Major Business
9.1.3 Pfizer Modified NSAIDs Product and Services
9.1.4 Pfizer Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Pfizer Recent Developments/Updates
9.1.6 Pfizer Competitive Strengths & Weaknesses
9.2 Novartis
9.2.1 Novartis Details
9.2.2 Novartis Major Business
9.2.3 Novartis Modified NSAIDs Product and Services
9.2.4 Novartis Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Novartis Recent Developments/Updates
9.2.6 Novartis Competitive Strengths & Weaknesses
9.3 Bayer
9.3.1 Bayer Details
9.3.2 Bayer Major Business
9.3.3 Bayer Modified NSAIDs Product and Services
9.3.4 Bayer Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Bayer Recent Developments/Updates
9.3.6 Bayer Competitive Strengths & Weaknesses
9.4 AbbVie
9.4.1 AbbVie Details
9.4.2 AbbVie Major Business
9.4.3 AbbVie Modified NSAIDs Product and Services
9.4.4 AbbVie Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 AbbVie Recent Developments/Updates
9.4.6 AbbVie Competitive Strengths & Weaknesses
9.5 Takeda
9.5.1 Takeda Details
9.5.2 Takeda Major Business
9.5.3 Takeda Modified NSAIDs Product and Services
9.5.4 Takeda Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Takeda Recent Developments/Updates
9.5.6 Takeda Competitive Strengths & Weaknesses
9.6 Sanofi
9.6.1 Sanofi Details
9.6.2 Sanofi Major Business
9.6.3 Sanofi Modified NSAIDs Product and Services
9.6.4 Sanofi Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Sanofi Recent Developments/Updates
9.6.6 Sanofi Competitive Strengths & Weaknesses
9.7 GSK
9.7.1 GSK Details
9.7.2 GSK Major Business
9.7.3 GSK Modified NSAIDs Product and Services
9.7.4 GSK Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 GSK Recent Developments/Updates
9.7.6 GSK Competitive Strengths & Weaknesses
9.8 Johnson & Johnson
9.8.1 Johnson & Johnson Details
9.8.2 Johnson & Johnson Major Business
9.8.3 Johnson & Johnson Modified NSAIDs Product and Services
9.8.4 Johnson & Johnson Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Johnson & Johnson Recent Developments/Updates
9.8.6 Johnson & Johnson Competitive Strengths & Weaknesses
9.9 Teva
9.9.1 Teva Details
9.9.2 Teva Major Business
9.9.3 Teva Modified NSAIDs Product and Services
9.9.4 Teva Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Teva Recent Developments/Updates
9.9.6 Teva Competitive Strengths & Weaknesses
9.10 Sun Pharma
9.10.1 Sun Pharma Details
9.10.2 Sun Pharma Major Business
9.10.3 Sun Pharma Modified NSAIDs Product and Services
9.10.4 Sun Pharma Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Sun Pharma Recent Developments/Updates
9.10.6 Sun Pharma Competitive Strengths & Weaknesses
9.11 Cipla
9.11.1 Cipla Details
9.11.2 Cipla Major Business
9.11.3 Cipla Modified NSAIDs Product and Services
9.11.4 Cipla Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Cipla Recent Developments/Updates
9.11.6 Cipla Competitive Strengths & Weaknesses
9.12 Dr. Reddy's
9.12.1 Dr. Reddy's Details
9.12.2 Dr. Reddy's Major Business
9.12.3 Dr. Reddy's Modified NSAIDs Product and Services
9.12.4 Dr. Reddy's Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Dr. Reddy's Recent Developments/Updates
9.12.6 Dr. Reddy's Competitive Strengths & Weaknesses
9.13 Aurobindo
9.13.1 Aurobindo Details
9.13.2 Aurobindo Major Business
9.13.3 Aurobindo Modified NSAIDs Product and Services
9.13.4 Aurobindo Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Aurobindo Recent Developments/Updates
9.13.6 Aurobindo Competitive Strengths & Weaknesses
9.14 Zydus Cadila
9.14.1 Zydus Cadila Details
9.14.2 Zydus Cadila Major Business
9.14.3 Zydus Cadila Modified NSAIDs Product and Services
9.14.4 Zydus Cadila Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Zydus Cadila Recent Developments/Updates
9.14.6 Zydus Cadila Competitive Strengths & Weaknesses
9.15 Torrent Pharma
9.15.1 Torrent Pharma Details
9.15.2 Torrent Pharma Major Business
9.15.3 Torrent Pharma Modified NSAIDs Product and Services
9.15.4 Torrent Pharma Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Torrent Pharma Recent Developments/Updates
9.15.6 Torrent Pharma Competitive Strengths & Weaknesses
9.16 Viatris
9.16.1 Viatris Details
9.16.2 Viatris Major Business
9.16.3 Viatris Modified NSAIDs Product and Services
9.16.4 Viatris Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Viatris Recent Developments/Updates
9.16.6 Viatris Competitive Strengths & Weaknesses
9.17 Apotex
9.17.1 Apotex Details
9.17.2 Apotex Major Business
9.17.3 Apotex Modified NSAIDs Product and Services
9.17.4 Apotex Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Apotex Recent Developments/Updates
9.17.6 Apotex Competitive Strengths & Weaknesses
9.18 Hikma
9.18.1 Hikma Details
9.18.2 Hikma Major Business
9.18.3 Hikma Modified NSAIDs Product and Services
9.18.4 Hikma Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Hikma Recent Developments/Updates
9.18.6 Hikma Competitive Strengths & Weaknesses
9.19 Jiangsu Hengrui Pharmaceuticals
9.19.1 Jiangsu Hengrui Pharmaceuticals Details
9.19.2 Jiangsu Hengrui Pharmaceuticals Major Business
9.19.3 Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Product and Services
9.19.4 Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
9.19.6 Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
9.20 Suzhou Homesun Pharmaceutical
9.20.1 Suzhou Homesun Pharmaceutical Details
9.20.2 Suzhou Homesun Pharmaceutical Major Business
9.20.3 Suzhou Homesun Pharmaceutical Modified NSAIDs Product and Services
9.20.4 Suzhou Homesun Pharmaceutical Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Suzhou Homesun Pharmaceutical Recent Developments/Updates
9.20.6 Suzhou Homesun Pharmaceutical Competitive Strengths & Weaknesses
9.21 CSPC Pharmaceutical
9.21.1 CSPC Pharmaceutical Details
9.21.2 CSPC Pharmaceutical Major Business
9.21.3 CSPC Pharmaceutical Modified NSAIDs Product and Services
9.21.4 CSPC Pharmaceutical Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 CSPC Pharmaceutical Recent Developments/Updates
9.21.6 CSPC Pharmaceutical Competitive Strengths & Weaknesses
9.22 Zhejiang Sundoc Pharmaceutical
9.22.1 Zhejiang Sundoc Pharmaceutical Details
9.22.2 Zhejiang Sundoc Pharmaceutical Major Business
9.22.3 Zhejiang Sundoc Pharmaceutical Modified NSAIDs Product and Services
9.22.4 Zhejiang Sundoc Pharmaceutical Modified NSAIDs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 Zhejiang Sundoc Pharmaceutical Recent Developments/Updates
9.22.6 Zhejiang Sundoc Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Modified NSAIDs Industry Chain
10.2 Modified NSAIDs Upstream Analysis
10.2.1 Modified NSAIDs Core Raw Materials
10.2.2 Main Manufacturers of Modified NSAIDs Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Modified NSAIDs Production Mode
10.6 Modified NSAIDs Procurement Model
10.7 Modified NSAIDs Industry Sales Model and Sales Channels
10.7.1 Modified NSAIDs Sales Model
10.7.2 Modified NSAIDs Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Modified NSAIDs Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Modified NSAIDs Production Value by Region (2021-2026) & (USD Million)
Table 3. World Modified NSAIDs Production Value by Region (2027-2032) & (USD Million)
Table 4. World Modified NSAIDs Production Value Market Share by Region (2021-2026)
Table 5. World Modified NSAIDs Production Value Market Share by Region (2027-2032)
Table 6. World Modified NSAIDs Production by Region (2021-2026) & (Tons)
Table 7. World Modified NSAIDs Production by Region (2027-2032) & (Tons)
Table 8. World Modified NSAIDs Production Market Share by Region (2021-2026)
Table 9. World Modified NSAIDs Production Market Share by Region (2027-2032)
Table 10. World Modified NSAIDs Average Price by Region (2021-2026) & (US$/kg)
Table 11. World Modified NSAIDs Average Price by Region (2027-2032) & (US$/kg)
Table 12. Modified NSAIDs Major Market Trends
Table 13. World Modified NSAIDs Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World Modified NSAIDs Consumption by Region (2021-2026) & (Tons)
Table 15. World Modified NSAIDs Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World Modified NSAIDs Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Modified NSAIDs Producers in 2025
Table 18. World Modified NSAIDs Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key Modified NSAIDs Producers in 2025
Table 20. World Modified NSAIDs Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 21. Global Modified NSAIDs Company Evaluation Quadrant
Table 22. World Modified NSAIDs Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Modified NSAIDs Production Site of Key Manufacturer
Table 24. Modified NSAIDs Market: Company Product Type Footprint
Table 25. Modified NSAIDs Market: Company Product Application Footprint
Table 26. Modified NSAIDs Competitive Factors
Table 27. Modified NSAIDs New Entrant and Capacity Expansion Plans
Table 28. Modified NSAIDs Mergers & Acquisitions Activity
Table 29. United States VS China Modified NSAIDs Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Modified NSAIDs Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China Modified NSAIDs Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based Modified NSAIDs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Modified NSAIDs Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Modified NSAIDs Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Modified NSAIDs Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers Modified NSAIDs Production Market Share (2021-2026)
Table 37. China Based Modified NSAIDs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Modified NSAIDs Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Modified NSAIDs Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Modified NSAIDs Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers Modified NSAIDs Production Market Share (2021-2026)
Table 42. Rest of World Based Modified NSAIDs Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Modified NSAIDs Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Modified NSAIDs Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Modified NSAIDs Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers Modified NSAIDs Production Market Share (2021-2026)
Table 47. World Modified NSAIDs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Modified NSAIDs Production by Type (2021-2026) & (Tons)
Table 49. World Modified NSAIDs Production by Type (2027-2032) & (Tons)
Table 50. World Modified NSAIDs Production Value by Type (2021-2026) & (USD Million)
Table 51. World Modified NSAIDs Production Value by Type (2027-2032) & (USD Million)
Table 52. World Modified NSAIDs Average Price by Type (2021-2026) & (US$/kg)
Table 53. World Modified NSAIDs Average Price by Type (2027-2032) & (US$/kg)
Table 54. World Modified NSAIDs Production Value by Application Scenarios, (USD Million), 2021 & 2025 & 2032
Table 55. World Modified NSAIDs Production by Application Scenarios (2021-2026) & (Tons)
Table 56. World Modified NSAIDs Production by Application Scenarios (2027-2032) & (Tons)
Table 57. World Modified NSAIDs Production Value by Application Scenarios (2021-2026) & (USD Million)
Table 58. World Modified NSAIDs Production Value by Application Scenarios (2027-2032) & (USD Million)
Table 59. World Modified NSAIDs Average Price by Application Scenarios (2021-2026) & (US$/kg)
Table 60. World Modified NSAIDs Average Price by Application Scenarios (2027-2032) & (US$/kg)
Table 61. World Modified NSAIDs Production Value by Manufacturing Process, (USD Million), 2021 & 2025 & 2032
Table 62. World Modified NSAIDs Production by Manufacturing Process (2021-2026) & (Tons)
Table 63. World Modified NSAIDs Production by Manufacturing Process (2027-2032) & (Tons)
Table 64. World Modified NSAIDs Production Value by Manufacturing Process (2021-2026) & (USD Million)
Table 65. World Modified NSAIDs Production Value by Manufacturing Process (2027-2032) & (USD Million)
Table 66. World Modified NSAIDs Average Price by Manufacturing Process (2021-2026) & (US$/kg)
Table 67. World Modified NSAIDs Average Price by Manufacturing Process (2027-2032) & (US$/kg)
Table 68. World Modified NSAIDs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Modified NSAIDs Production by Application (2021-2026) & (Tons)
Table 70. World Modified NSAIDs Production by Application (2027-2032) & (Tons)
Table 71. World Modified NSAIDs Production Value by Application (2021-2026) & (USD Million)
Table 72. World Modified NSAIDs Production Value by Application (2027-2032) & (USD Million)
Table 73. World Modified NSAIDs Average Price by Application (2021-2026) & (US$/kg)
Table 74. World Modified NSAIDs Average Price by Application (2027-2032) & (US$/kg)
Table 75. Pfizer Basic Information, Manufacturing Base and Competitors
Table 76. Pfizer Major Business
Table 77. Pfizer Modified NSAIDs Product and Services
Table 78. Pfizer Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Pfizer Recent Developments/Updates
Table 80. Pfizer Competitive Strengths & Weaknesses
Table 81. Novartis Basic Information, Manufacturing Base and Competitors
Table 82. Novartis Major Business
Table 83. Novartis Modified NSAIDs Product and Services
Table 84. Novartis Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Novartis Recent Developments/Updates
Table 86. Novartis Competitive Strengths & Weaknesses
Table 87. Bayer Basic Information, Manufacturing Base and Competitors
Table 88. Bayer Major Business
Table 89. Bayer Modified NSAIDs Product and Services
Table 90. Bayer Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Bayer Recent Developments/Updates
Table 92. Bayer Competitive Strengths & Weaknesses
Table 93. AbbVie Basic Information, Manufacturing Base and Competitors
Table 94. AbbVie Major Business
Table 95. AbbVie Modified NSAIDs Product and Services
Table 96. AbbVie Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. AbbVie Recent Developments/Updates
Table 98. AbbVie Competitive Strengths & Weaknesses
Table 99. Takeda Basic Information, Manufacturing Base and Competitors
Table 100. Takeda Major Business
Table 101. Takeda Modified NSAIDs Product and Services
Table 102. Takeda Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Takeda Recent Developments/Updates
Table 104. Takeda Competitive Strengths & Weaknesses
Table 105. Sanofi Basic Information, Manufacturing Base and Competitors
Table 106. Sanofi Major Business
Table 107. Sanofi Modified NSAIDs Product and Services
Table 108. Sanofi Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Sanofi Recent Developments/Updates
Table 110. Sanofi Competitive Strengths & Weaknesses
Table 111. GSK Basic Information, Manufacturing Base and Competitors
Table 112. GSK Major Business
Table 113. GSK Modified NSAIDs Product and Services
Table 114. GSK Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. GSK Recent Developments/Updates
Table 116. GSK Competitive Strengths & Weaknesses
Table 117. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 118. Johnson & Johnson Major Business
Table 119. Johnson & Johnson Modified NSAIDs Product and Services
Table 120. Johnson & Johnson Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Johnson & Johnson Recent Developments/Updates
Table 122. Johnson & Johnson Competitive Strengths & Weaknesses
Table 123. Teva Basic Information, Manufacturing Base and Competitors
Table 124. Teva Major Business
Table 125. Teva Modified NSAIDs Product and Services
Table 126. Teva Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Teva Recent Developments/Updates
Table 128. Teva Competitive Strengths & Weaknesses
Table 129. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 130. Sun Pharma Major Business
Table 131. Sun Pharma Modified NSAIDs Product and Services
Table 132. Sun Pharma Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Sun Pharma Recent Developments/Updates
Table 134. Sun Pharma Competitive Strengths & Weaknesses
Table 135. Cipla Basic Information, Manufacturing Base and Competitors
Table 136. Cipla Major Business
Table 137. Cipla Modified NSAIDs Product and Services
Table 138. Cipla Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Cipla Recent Developments/Updates
Table 140. Cipla Competitive Strengths & Weaknesses
Table 141. Dr. Reddy's Basic Information, Manufacturing Base and Competitors
Table 142. Dr. Reddy's Major Business
Table 143. Dr. Reddy's Modified NSAIDs Product and Services
Table 144. Dr. Reddy's Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Dr. Reddy's Recent Developments/Updates
Table 146. Dr. Reddy's Competitive Strengths & Weaknesses
Table 147. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 148. Aurobindo Major Business
Table 149. Aurobindo Modified NSAIDs Product and Services
Table 150. Aurobindo Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Aurobindo Recent Developments/Updates
Table 152. Aurobindo Competitive Strengths & Weaknesses
Table 153. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 154. Zydus Cadila Major Business
Table 155. Zydus Cadila Modified NSAIDs Product and Services
Table 156. Zydus Cadila Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Zydus Cadila Recent Developments/Updates
Table 158. Zydus Cadila Competitive Strengths & Weaknesses
Table 159. Torrent Pharma Basic Information, Manufacturing Base and Competitors
Table 160. Torrent Pharma Major Business
Table 161. Torrent Pharma Modified NSAIDs Product and Services
Table 162. Torrent Pharma Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Torrent Pharma Recent Developments/Updates
Table 164. Torrent Pharma Competitive Strengths & Weaknesses
Table 165. Viatris Basic Information, Manufacturing Base and Competitors
Table 166. Viatris Major Business
Table 167. Viatris Modified NSAIDs Product and Services
Table 168. Viatris Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Viatris Recent Developments/Updates
Table 170. Viatris Competitive Strengths & Weaknesses
Table 171. Apotex Basic Information, Manufacturing Base and Competitors
Table 172. Apotex Major Business
Table 173. Apotex Modified NSAIDs Product and Services
Table 174. Apotex Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Apotex Recent Developments/Updates
Table 176. Apotex Competitive Strengths & Weaknesses
Table 177. Hikma Basic Information, Manufacturing Base and Competitors
Table 178. Hikma Major Business
Table 179. Hikma Modified NSAIDs Product and Services
Table 180. Hikma Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Hikma Recent Developments/Updates
Table 182. Hikma Competitive Strengths & Weaknesses
Table 183. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 184. Jiangsu Hengrui Pharmaceuticals Major Business
Table 185. Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Product and Services
Table 186. Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 188. Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
Table 189. Suzhou Homesun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 190. Suzhou Homesun Pharmaceutical Major Business
Table 191. Suzhou Homesun Pharmaceutical Modified NSAIDs Product and Services
Table 192. Suzhou Homesun Pharmaceutical Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Suzhou Homesun Pharmaceutical Recent Developments/Updates
Table 194. Suzhou Homesun Pharmaceutical Competitive Strengths & Weaknesses
Table 195. CSPC Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 196. CSPC Pharmaceutical Major Business
Table 197. CSPC Pharmaceutical Modified NSAIDs Product and Services
Table 198. CSPC Pharmaceutical Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. CSPC Pharmaceutical Recent Developments/Updates
Table 200. CSPC Pharmaceutical Competitive Strengths & Weaknesses
Table 201. Zhejiang Sundoc Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 202. Zhejiang Sundoc Pharmaceutical Major Business
Table 203. Zhejiang Sundoc Pharmaceutical Modified NSAIDs Product and Services
Table 204. Zhejiang Sundoc Pharmaceutical Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Zhejiang Sundoc Pharmaceutical Recent Developments/Updates
Table 206. Zhejiang Sundoc Pharmaceutical Competitive Strengths & Weaknesses
Table 207. Global Key Players of Modified NSAIDs Upstream (Raw Materials)
Table 208. Global Modified NSAIDs Typical Customers
Table 209. Modified NSAIDs Typical Distributors
Table 1. World Modified NSAIDs Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Modified NSAIDs Production Value by Region (2021-2026) & (USD Million)
Table 3. World Modified NSAIDs Production Value by Region (2027-2032) & (USD Million)
Table 4. World Modified NSAIDs Production Value Market Share by Region (2021-2026)
Table 5. World Modified NSAIDs Production Value Market Share by Region (2027-2032)
Table 6. World Modified NSAIDs Production by Region (2021-2026) & (Tons)
Table 7. World Modified NSAIDs Production by Region (2027-2032) & (Tons)
Table 8. World Modified NSAIDs Production Market Share by Region (2021-2026)
Table 9. World Modified NSAIDs Production Market Share by Region (2027-2032)
Table 10. World Modified NSAIDs Average Price by Region (2021-2026) & (US$/kg)
Table 11. World Modified NSAIDs Average Price by Region (2027-2032) & (US$/kg)
Table 12. Modified NSAIDs Major Market Trends
Table 13. World Modified NSAIDs Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World Modified NSAIDs Consumption by Region (2021-2026) & (Tons)
Table 15. World Modified NSAIDs Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World Modified NSAIDs Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Modified NSAIDs Producers in 2025
Table 18. World Modified NSAIDs Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key Modified NSAIDs Producers in 2025
Table 20. World Modified NSAIDs Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 21. Global Modified NSAIDs Company Evaluation Quadrant
Table 22. World Modified NSAIDs Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Modified NSAIDs Production Site of Key Manufacturer
Table 24. Modified NSAIDs Market: Company Product Type Footprint
Table 25. Modified NSAIDs Market: Company Product Application Footprint
Table 26. Modified NSAIDs Competitive Factors
Table 27. Modified NSAIDs New Entrant and Capacity Expansion Plans
Table 28. Modified NSAIDs Mergers & Acquisitions Activity
Table 29. United States VS China Modified NSAIDs Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Modified NSAIDs Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China Modified NSAIDs Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based Modified NSAIDs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Modified NSAIDs Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Modified NSAIDs Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Modified NSAIDs Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers Modified NSAIDs Production Market Share (2021-2026)
Table 37. China Based Modified NSAIDs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Modified NSAIDs Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Modified NSAIDs Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Modified NSAIDs Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers Modified NSAIDs Production Market Share (2021-2026)
Table 42. Rest of World Based Modified NSAIDs Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Modified NSAIDs Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Modified NSAIDs Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Modified NSAIDs Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers Modified NSAIDs Production Market Share (2021-2026)
Table 47. World Modified NSAIDs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Modified NSAIDs Production by Type (2021-2026) & (Tons)
Table 49. World Modified NSAIDs Production by Type (2027-2032) & (Tons)
Table 50. World Modified NSAIDs Production Value by Type (2021-2026) & (USD Million)
Table 51. World Modified NSAIDs Production Value by Type (2027-2032) & (USD Million)
Table 52. World Modified NSAIDs Average Price by Type (2021-2026) & (US$/kg)
Table 53. World Modified NSAIDs Average Price by Type (2027-2032) & (US$/kg)
Table 54. World Modified NSAIDs Production Value by Application Scenarios, (USD Million), 2021 & 2025 & 2032
Table 55. World Modified NSAIDs Production by Application Scenarios (2021-2026) & (Tons)
Table 56. World Modified NSAIDs Production by Application Scenarios (2027-2032) & (Tons)
Table 57. World Modified NSAIDs Production Value by Application Scenarios (2021-2026) & (USD Million)
Table 58. World Modified NSAIDs Production Value by Application Scenarios (2027-2032) & (USD Million)
Table 59. World Modified NSAIDs Average Price by Application Scenarios (2021-2026) & (US$/kg)
Table 60. World Modified NSAIDs Average Price by Application Scenarios (2027-2032) & (US$/kg)
Table 61. World Modified NSAIDs Production Value by Manufacturing Process, (USD Million), 2021 & 2025 & 2032
Table 62. World Modified NSAIDs Production by Manufacturing Process (2021-2026) & (Tons)
Table 63. World Modified NSAIDs Production by Manufacturing Process (2027-2032) & (Tons)
Table 64. World Modified NSAIDs Production Value by Manufacturing Process (2021-2026) & (USD Million)
Table 65. World Modified NSAIDs Production Value by Manufacturing Process (2027-2032) & (USD Million)
Table 66. World Modified NSAIDs Average Price by Manufacturing Process (2021-2026) & (US$/kg)
Table 67. World Modified NSAIDs Average Price by Manufacturing Process (2027-2032) & (US$/kg)
Table 68. World Modified NSAIDs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Modified NSAIDs Production by Application (2021-2026) & (Tons)
Table 70. World Modified NSAIDs Production by Application (2027-2032) & (Tons)
Table 71. World Modified NSAIDs Production Value by Application (2021-2026) & (USD Million)
Table 72. World Modified NSAIDs Production Value by Application (2027-2032) & (USD Million)
Table 73. World Modified NSAIDs Average Price by Application (2021-2026) & (US$/kg)
Table 74. World Modified NSAIDs Average Price by Application (2027-2032) & (US$/kg)
Table 75. Pfizer Basic Information, Manufacturing Base and Competitors
Table 76. Pfizer Major Business
Table 77. Pfizer Modified NSAIDs Product and Services
Table 78. Pfizer Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Pfizer Recent Developments/Updates
Table 80. Pfizer Competitive Strengths & Weaknesses
Table 81. Novartis Basic Information, Manufacturing Base and Competitors
Table 82. Novartis Major Business
Table 83. Novartis Modified NSAIDs Product and Services
Table 84. Novartis Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Novartis Recent Developments/Updates
Table 86. Novartis Competitive Strengths & Weaknesses
Table 87. Bayer Basic Information, Manufacturing Base and Competitors
Table 88. Bayer Major Business
Table 89. Bayer Modified NSAIDs Product and Services
Table 90. Bayer Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Bayer Recent Developments/Updates
Table 92. Bayer Competitive Strengths & Weaknesses
Table 93. AbbVie Basic Information, Manufacturing Base and Competitors
Table 94. AbbVie Major Business
Table 95. AbbVie Modified NSAIDs Product and Services
Table 96. AbbVie Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. AbbVie Recent Developments/Updates
Table 98. AbbVie Competitive Strengths & Weaknesses
Table 99. Takeda Basic Information, Manufacturing Base and Competitors
Table 100. Takeda Major Business
Table 101. Takeda Modified NSAIDs Product and Services
Table 102. Takeda Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Takeda Recent Developments/Updates
Table 104. Takeda Competitive Strengths & Weaknesses
Table 105. Sanofi Basic Information, Manufacturing Base and Competitors
Table 106. Sanofi Major Business
Table 107. Sanofi Modified NSAIDs Product and Services
Table 108. Sanofi Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Sanofi Recent Developments/Updates
Table 110. Sanofi Competitive Strengths & Weaknesses
Table 111. GSK Basic Information, Manufacturing Base and Competitors
Table 112. GSK Major Business
Table 113. GSK Modified NSAIDs Product and Services
Table 114. GSK Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. GSK Recent Developments/Updates
Table 116. GSK Competitive Strengths & Weaknesses
Table 117. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 118. Johnson & Johnson Major Business
Table 119. Johnson & Johnson Modified NSAIDs Product and Services
Table 120. Johnson & Johnson Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Johnson & Johnson Recent Developments/Updates
Table 122. Johnson & Johnson Competitive Strengths & Weaknesses
Table 123. Teva Basic Information, Manufacturing Base and Competitors
Table 124. Teva Major Business
Table 125. Teva Modified NSAIDs Product and Services
Table 126. Teva Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Teva Recent Developments/Updates
Table 128. Teva Competitive Strengths & Weaknesses
Table 129. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 130. Sun Pharma Major Business
Table 131. Sun Pharma Modified NSAIDs Product and Services
Table 132. Sun Pharma Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Sun Pharma Recent Developments/Updates
Table 134. Sun Pharma Competitive Strengths & Weaknesses
Table 135. Cipla Basic Information, Manufacturing Base and Competitors
Table 136. Cipla Major Business
Table 137. Cipla Modified NSAIDs Product and Services
Table 138. Cipla Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Cipla Recent Developments/Updates
Table 140. Cipla Competitive Strengths & Weaknesses
Table 141. Dr. Reddy's Basic Information, Manufacturing Base and Competitors
Table 142. Dr. Reddy's Major Business
Table 143. Dr. Reddy's Modified NSAIDs Product and Services
Table 144. Dr. Reddy's Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Dr. Reddy's Recent Developments/Updates
Table 146. Dr. Reddy's Competitive Strengths & Weaknesses
Table 147. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 148. Aurobindo Major Business
Table 149. Aurobindo Modified NSAIDs Product and Services
Table 150. Aurobindo Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Aurobindo Recent Developments/Updates
Table 152. Aurobindo Competitive Strengths & Weaknesses
Table 153. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 154. Zydus Cadila Major Business
Table 155. Zydus Cadila Modified NSAIDs Product and Services
Table 156. Zydus Cadila Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Zydus Cadila Recent Developments/Updates
Table 158. Zydus Cadila Competitive Strengths & Weaknesses
Table 159. Torrent Pharma Basic Information, Manufacturing Base and Competitors
Table 160. Torrent Pharma Major Business
Table 161. Torrent Pharma Modified NSAIDs Product and Services
Table 162. Torrent Pharma Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Torrent Pharma Recent Developments/Updates
Table 164. Torrent Pharma Competitive Strengths & Weaknesses
Table 165. Viatris Basic Information, Manufacturing Base and Competitors
Table 166. Viatris Major Business
Table 167. Viatris Modified NSAIDs Product and Services
Table 168. Viatris Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Viatris Recent Developments/Updates
Table 170. Viatris Competitive Strengths & Weaknesses
Table 171. Apotex Basic Information, Manufacturing Base and Competitors
Table 172. Apotex Major Business
Table 173. Apotex Modified NSAIDs Product and Services
Table 174. Apotex Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Apotex Recent Developments/Updates
Table 176. Apotex Competitive Strengths & Weaknesses
Table 177. Hikma Basic Information, Manufacturing Base and Competitors
Table 178. Hikma Major Business
Table 179. Hikma Modified NSAIDs Product and Services
Table 180. Hikma Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Hikma Recent Developments/Updates
Table 182. Hikma Competitive Strengths & Weaknesses
Table 183. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 184. Jiangsu Hengrui Pharmaceuticals Major Business
Table 185. Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Product and Services
Table 186. Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 188. Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
Table 189. Suzhou Homesun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 190. Suzhou Homesun Pharmaceutical Major Business
Table 191. Suzhou Homesun Pharmaceutical Modified NSAIDs Product and Services
Table 192. Suzhou Homesun Pharmaceutical Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Suzhou Homesun Pharmaceutical Recent Developments/Updates
Table 194. Suzhou Homesun Pharmaceutical Competitive Strengths & Weaknesses
Table 195. CSPC Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 196. CSPC Pharmaceutical Major Business
Table 197. CSPC Pharmaceutical Modified NSAIDs Product and Services
Table 198. CSPC Pharmaceutical Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. CSPC Pharmaceutical Recent Developments/Updates
Table 200. CSPC Pharmaceutical Competitive Strengths & Weaknesses
Table 201. Zhejiang Sundoc Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 202. Zhejiang Sundoc Pharmaceutical Major Business
Table 203. Zhejiang Sundoc Pharmaceutical Modified NSAIDs Product and Services
Table 204. Zhejiang Sundoc Pharmaceutical Modified NSAIDs Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Zhejiang Sundoc Pharmaceutical Recent Developments/Updates
Table 206. Zhejiang Sundoc Pharmaceutical Competitive Strengths & Weaknesses
Table 207. Global Key Players of Modified NSAIDs Upstream (Raw Materials)
Table 208. Global Modified NSAIDs Typical Customers
Table 209. Modified NSAIDs Typical Distributors
LIST OF FIGURES
Figure 1. Modified NSAIDs Picture
Figure 2. World Modified NSAIDs Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Modified NSAIDs Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Modified NSAIDs Production (2021-2032) & (Tons)
Figure 5. World Modified NSAIDs Average Price (2021-2032) & (US$/kg)
Figure 6. World Modified NSAIDs Production Value Market Share by Region (2021-2032)
Figure 7. World Modified NSAIDs Production Market Share by Region (2021-2032)
Figure 8. North America Modified NSAIDs Production (2021-2032) & (Tons)
Figure 9. Europe Modified NSAIDs Production (2021-2032) & (Tons)
Figure 10. China Modified NSAIDs Production (2021-2032) & (Tons)
Figure 11. Japan Modified NSAIDs Production (2021-2032) & (Tons)
Figure 12. India Modified NSAIDs Production (2021-2032) & (Tons)
Figure 13. Modified NSAIDs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Modified NSAIDs Consumption (2021-2032) & (Tons)
Figure 16. World Modified NSAIDs Consumption Market Share by Region (2021-2032)
Figure 17. United States Modified NSAIDs Consumption (2021-2032) & (Tons)
Figure 18. China Modified NSAIDs Consumption (2021-2032) & (Tons)
Figure 19. Europe Modified NSAIDs Consumption (2021-2032) & (Tons)
Figure 20. Japan Modified NSAIDs Consumption (2021-2032) & (Tons)
Figure 21. South Korea Modified NSAIDs Consumption (2021-2032) & (Tons)
Figure 22. ASEAN Modified NSAIDs Consumption (2021-2032) & (Tons)
Figure 23. India Modified NSAIDs Consumption (2021-2032) & (Tons)
Figure 24. Producer Shipments of Modified NSAIDs by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Modified NSAIDs Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Modified NSAIDs Markets in 2025
Figure 27. United States VS China: Modified NSAIDs Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Modified NSAIDs Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Modified NSAIDs Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Modified NSAIDs Production Market Share 2025
Figure 31. China Based Manufacturers Modified NSAIDs Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Modified NSAIDs Production Market Share 2025
Figure 33. World Modified NSAIDs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Modified NSAIDs Production Value Market Share by Type in 2025
Figure 35. COX-2 Selective Inhibitors
Figure 36. NO-NSAIDs (Nitric Oxide Releasers)
Figure 37. Others
Figure 38. World Modified NSAIDs Production Market Share by Type (2021-2032)
Figure 39. World Modified NSAIDs Production Value Market Share by Type (2021-2032)
Figure 40. World Modified NSAIDs Average Price by Type (2021-2032) & (US$/kg)
Figure 41. World Modified NSAIDs Production Value by Application Scenarios, (USD Million), 2021 & 2025 & 2032
Figure 42. World Modified NSAIDs Production Value Market Share by Application Scenarios in 2025
Figure 43. Acute Pain Management
Figure 44. Chronic Inflammation (Rheumatoid Arthritis, Osteoarthritis)
Figure 45. Others
Figure 46. World Modified NSAIDs Production Market Share by Application Scenarios (2021-2032)
Figure 47. World Modified NSAIDs Production Value Market Share by Application Scenarios (2021-2032)
Figure 48. World Modified NSAIDs Average Price by Application Scenarios (2021-2032) & (US$/kg)
Figure 49. World Modified NSAIDs Production Value by Manufacturing Process, (USD Million), 2021 & 2025 & 2032
Figure 50. World Modified NSAIDs Production Value Market Share by Manufacturing Process in 2025
Figure 51. Sustained-Release/Controlled-ReleaseTablets
Figure 52. Transdermal Patches, Gels
Figure 53. Microencapsulated Formulations
Figure 54. World Modified NSAIDs Production Market Share by Manufacturing Process (2021-2032)
Figure 55. World Modified NSAIDs Production Value Market Share by Manufacturing Process (2021-2032)
Figure 56. World Modified NSAIDs Average Price by Manufacturing Process (2021-2032) & (US$/kg)
Figure 57. World Modified NSAIDs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World Modified NSAIDs Production Value Market Share by Application in 2025
Figure 59. Hospital Clinical Department
Figure 60. Sports Medicine
Figure 61. Others
Figure 62. World Modified NSAIDs Production Market Share by Application (2021-2032)
Figure 63. World Modified NSAIDs Production Value Market Share by Application (2021-2032)
Figure 64. World Modified NSAIDs Average Price by Application (2021-2032) & (US$/kg)
Figure 65. Modified NSAIDs Industry Chain
Figure 66. Modified NSAIDs Procurement Model
Figure 67. Modified NSAIDs Sales Model
Figure 68. Modified NSAIDs Sales Channels, Direct Sales, and Distribution
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. Modified NSAIDs Picture
Figure 2. World Modified NSAIDs Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Modified NSAIDs Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Modified NSAIDs Production (2021-2032) & (Tons)
Figure 5. World Modified NSAIDs Average Price (2021-2032) & (US$/kg)
Figure 6. World Modified NSAIDs Production Value Market Share by Region (2021-2032)
Figure 7. World Modified NSAIDs Production Market Share by Region (2021-2032)
Figure 8. North America Modified NSAIDs Production (2021-2032) & (Tons)
Figure 9. Europe Modified NSAIDs Production (2021-2032) & (Tons)
Figure 10. China Modified NSAIDs Production (2021-2032) & (Tons)
Figure 11. Japan Modified NSAIDs Production (2021-2032) & (Tons)
Figure 12. India Modified NSAIDs Production (2021-2032) & (Tons)
Figure 13. Modified NSAIDs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Modified NSAIDs Consumption (2021-2032) & (Tons)
Figure 16. World Modified NSAIDs Consumption Market Share by Region (2021-2032)
Figure 17. United States Modified NSAIDs Consumption (2021-2032) & (Tons)
Figure 18. China Modified NSAIDs Consumption (2021-2032) & (Tons)
Figure 19. Europe Modified NSAIDs Consumption (2021-2032) & (Tons)
Figure 20. Japan Modified NSAIDs Consumption (2021-2032) & (Tons)
Figure 21. South Korea Modified NSAIDs Consumption (2021-2032) & (Tons)
Figure 22. ASEAN Modified NSAIDs Consumption (2021-2032) & (Tons)
Figure 23. India Modified NSAIDs Consumption (2021-2032) & (Tons)
Figure 24. Producer Shipments of Modified NSAIDs by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Modified NSAIDs Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Modified NSAIDs Markets in 2025
Figure 27. United States VS China: Modified NSAIDs Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Modified NSAIDs Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Modified NSAIDs Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Modified NSAIDs Production Market Share 2025
Figure 31. China Based Manufacturers Modified NSAIDs Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Modified NSAIDs Production Market Share 2025
Figure 33. World Modified NSAIDs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Modified NSAIDs Production Value Market Share by Type in 2025
Figure 35. COX-2 Selective Inhibitors
Figure 36. NO-NSAIDs (Nitric Oxide Releasers)
Figure 37. Others
Figure 38. World Modified NSAIDs Production Market Share by Type (2021-2032)
Figure 39. World Modified NSAIDs Production Value Market Share by Type (2021-2032)
Figure 40. World Modified NSAIDs Average Price by Type (2021-2032) & (US$/kg)
Figure 41. World Modified NSAIDs Production Value by Application Scenarios, (USD Million), 2021 & 2025 & 2032
Figure 42. World Modified NSAIDs Production Value Market Share by Application Scenarios in 2025
Figure 43. Acute Pain Management
Figure 44. Chronic Inflammation (Rheumatoid Arthritis, Osteoarthritis)
Figure 45. Others
Figure 46. World Modified NSAIDs Production Market Share by Application Scenarios (2021-2032)
Figure 47. World Modified NSAIDs Production Value Market Share by Application Scenarios (2021-2032)
Figure 48. World Modified NSAIDs Average Price by Application Scenarios (2021-2032) & (US$/kg)
Figure 49. World Modified NSAIDs Production Value by Manufacturing Process, (USD Million), 2021 & 2025 & 2032
Figure 50. World Modified NSAIDs Production Value Market Share by Manufacturing Process in 2025
Figure 51. Sustained-Release/Controlled-ReleaseTablets
Figure 52. Transdermal Patches, Gels
Figure 53. Microencapsulated Formulations
Figure 54. World Modified NSAIDs Production Market Share by Manufacturing Process (2021-2032)
Figure 55. World Modified NSAIDs Production Value Market Share by Manufacturing Process (2021-2032)
Figure 56. World Modified NSAIDs Average Price by Manufacturing Process (2021-2032) & (US$/kg)
Figure 57. World Modified NSAIDs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World Modified NSAIDs Production Value Market Share by Application in 2025
Figure 59. Hospital Clinical Department
Figure 60. Sports Medicine
Figure 61. Others
Figure 62. World Modified NSAIDs Production Market Share by Application (2021-2032)
Figure 63. World Modified NSAIDs Production Value Market Share by Application (2021-2032)
Figure 64. World Modified NSAIDs Average Price by Application (2021-2032) & (US$/kg)
Figure 65. Modified NSAIDs Industry Chain
Figure 66. Modified NSAIDs Procurement Model
Figure 67. Modified NSAIDs Sales Model
Figure 68. Modified NSAIDs Sales Channels, Direct Sales, and Distribution
Figure 69. Methodology
Figure 70. Research Process and Data Source
